All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â![MYDEKLA 60MG TABLET_1 MYDEKLA 60MG TABLET_1](https://assets.mrmed.in/product-images/product-images-1653653916456-405931293-MYDEKLA%2060MG%20TABLET_101129_1.jpg)
![MYDEKLA 60MG TABLET_2 MYDEKLA 60MG TABLET_2](https://assets.mrmed.in/product-images/product-images-1653653916458-176545403-MYDEKLA%2060MG%20TABLET_101129_2.jpg)
![MYDEKLA 60MG TABLET_3 MYDEKLA 60MG TABLET_3](https://assets.mrmed.in/product-images/product-images-1653653916459-145004801-MYDEKLA%2060MG%20TABLET_101129_3.jpg)
![MYDEKLA 60MG TABLET_1 MYDEKLA 60MG TABLET_1](https://assets.mrmed.in/product-images/product-images-1653653916456-405931293-MYDEKLA%2060MG%20TABLET_101129_1.jpg)
Mydekla 60mg Tablet
Prescription Required
Salt Composition : Daclatasvir
Manufacturer : MYLAN PHARMACEUTICALS PVT LTD
Origin of Medicine : India
28 Tablet(s) In A Bottle
Introduction to Mydekla 60mg Tablet
Mydekla 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). It works by stopping the virus that causes hepatitis C from spreading inside the body.Â
Do not take Mydekla 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.
Mydekla 60mg tablet is not recommended for patients below 18 years of age. Do not take this medicine if you are pregnant or breastfeeding. Use effective contraception during the treatment. The common side effects of this treatment are headache, tiredness, anemia, and nausea.
Uses of Mydekla 60mg Tablet
- Chronic hepatitis C virus
Therapeutic Effects of Mydekla 60mg Tablet
This medicine works by stopping the hepatitis C virus from multiplying and infecting new cells. This lowers the amount of hepatitis C virus in your body and removes the virus from your blood over a period of time.
Interaction of Mydekla 60mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interact with Mydekla 60mg tablet and reduce its effectiveness by causing undesirable side effects.
More Information about Mydekla 60mg Tablet
- Store at room temperature (20°C and 25°C).
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets
- If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
How to consume Mydekla 60mg Tablet
It is an orally available prescription drug. Your doctor will decide the dose and duration of Mydekla 60mg tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water.
Safety Advices for Mydekla 60mg Tablet
 Â
Pregnancy
 ÂDo not take Mydekla 60mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during and for 5 weeks after your last dose.
 Â
Breast Feeding
 ÂBreastfeeding is not recommended in patients taking Mydekla 60mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
 Â
Lungs
 ÂIt is unknown whether Mydekla 60mg tablet is safe to be administered in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
 Â
Liver
 ÂMydekla 60mg tablet is safe when administered in patients with liver diseases. Dose adjustments are not necessary. However, inform your physician if you have any liver diseases before initiating the therapy.
 Â
Alcohol
 ÂIt is unknown whether it is safe to drink alcohol while taking Daclatasvir. Consult your doctor for more information
 Â
Driving
 ÂIt is unsafe to drive after Mydekla 60mg tablet tablets because it may cause dizziness and drowsiness.
Side Effects of Mydekla 60mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Decreased heart rate
- Liver failure
- Reactivation of hepatitis B virus
CommonÂ
- Nausea
- Headache
- Tiredness
- Dizziness
Word of Advice
Take all of the medicine and complete the course of therapy even if you feel better after the first few doses. Do not take extra doses or medicine to make up for a missed dose. Avoid pregnancy during combination treatment with daclatasvir, sofosbuvir, and ribavirin for 6 months of stopping treatment. Tell your doctor right away if you or your partner becomes pregnant. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
FAQs
Q 1. Can Mydekla 60mg tablet be used to treat all types of hepatitis C?
Mydekla 60mg tablet is approved for treating chronic hepatitis C virus (HCV) infection, but its effectiveness may vary depending on the genotype of the virus. It is important to consult with a healthcare provider who can determine the appropriate treatment regimen based on the specific genotype and individual patient factors.
Q 2. Can Mydekla 60mg tablet interact with other medications?
Mydekla 60mg tablet can interact with several medications, including certain antiretroviral drugs, antifungal agents, and certain antibiotics. To prevent potential interactions, it is crucial to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and herbal supplements.
Q 3. Can Mydekla 60mg tablet prevent the transmission of hepatitis C?
Mydekla 60mg tablet is primarily used to treat chronic HCV infection in individuals who are already infected. It is not recommended for use as a preventive measure to avoid HCV transmission. Prevention strategies, such as practicing safe sex, avoiding sharing needles, and following appropriate infection control measures, should be implemented to reduce the risk of HCV transmission.
Q 4. Can I take Mydekla 60mg tablet while enjoying a cup of coffee or tea?
There are no known interactions between Mydekla 60mg tablet and caffeine. However, be sure to follow the instructions provided by your healthcare provider or the medication's label regarding the timing and conditions of Mydekla 60mg tablet administration.
Q 5. Can Mydekla 60mg tablet be taken with food?
Mydekla 60mg tablet can be taken with or without food. Taking it with a meal may help improve its absorption, but specific instructions may vary depending on the treatment regimen. It is important to follow the dosing instructions provided by your healthcare provider or refer to the medication's instructions for use.
Fact Box of Mydekla 60mg Tablet
Molecule name: Daclatasvir | Therapeutic class:Â Antiviral |
Pharmacological class: Hepatitis C virus (HCV) NS5A inhibitors | Indications: Chronic hepatitis C virus |
References
- Daclatasvir - Summary Of Product Characteristics; Revised 2020. Accessed May 16, 2023. https://www.ema.europa.eu/en/documents/product-information/daklinza-epar-product-information_en.pdf
- Daclatasvir - Highlights of Prescribing Information; Revised 2017. Accessed May 16, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206843s006lbl.pdf
- Yash Gandhi et al; Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics; Clinical Pharmacokinetics; Published on Aug 2018; Accessed May 16, 2023; https://pubmed.ncbi.nlm.nih.gov/29353349/
- Gillian M Keating; Daclatasvir: A Review in Chronic Hepatitis C; Drugs; Published on Sept 2016; Accessed May 16, 2023; https://pubmed.ncbi.nlm.nih.gov/27550544/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.